Company Filing History:
1 out of 3,539 
1 out of 2,489 
1 out of 1 
Years Active: 2019
Title: Salim Safurdeen Abdool Karim: Innovator in HIV Therapy
Introduction
Salim Safurdeen Abdool Karim is a prominent inventor based in Durban, South Africa. He is recognized for his significant contributions to the field of medical innovation, particularly in developing therapies to combat HIV. With one patent to his name, Karim is at the forefront of research aimed at improving the lives of individuals affected by this virus.
Latest Patents
Karim's notable patent is titled "Broadly neutralizing monoclonal antibodies against HIV-1 V1V2 Env region." This invention pertains to anti-HIV therapies and prophylaxis, specifically focusing on broadly neutralizing antibodies against HIV-1. The patent encompasses not only the antibodies themselves but also nucleic acids encoding these antibodies, vectors containing the nucleic acids, and various pharmaceutical compositions. The utilization of these antibodies and vectors aims to treat and prevent HIV-1 infection effectively. Furthermore, Karim's invention includes a kit designed to facilitate the use of the antibodies for therapeutic applications.
Career Highlights
Throughout his career, Salim Safurdeen Abdool Karim has worked alongside esteemed institutions and organizations. He has had associations with the United States of America, as represented by the Secretary, Department of Health and Human Services, and Columbia University in the City of New York. His work in these prestigious organizations showcases his commitment to advancing health innovations globally.
Collaborations
In the course of his research, Karim has collaborated with notable colleagues, including Chaim Aryeh Schramm and Jason Gorman. These partnerships reflect his engagement with other experts in the field, contributing to the development of groundbreaking therapies against HIV.
Conclusion
Salim Safurdeen Abdool Karim is a remarkable inventor whose work continues to impact the fight against HIV. His patent on broadly neutralizing monoclonal antibodies represents a significant advancement in anti-HIV therapy, showcasing the potential of scientific innovation in addressing critical health issues. With ongoing collaborations and research, Karim remains a key figure in the pursuit of effective solutions to the challenges posed by HIV infection.